This week, ZenPharm, the Maltese joint venture with Canadian cannabis producer, Zenabis Global, received its Maltese licence to process cannabis for medicinal use and research purposes out of its Hal Far Industrial Estate premises.
Kurt Farrugia, CEO of Malta Enterprise – the national economic development agency that assisted the company to set up locally – considers this “an important milestone for Malta’s medical cannabis industry.”
“We are gaining momentum with the production of cannabis for medical use in Malta,” he wrote. “Zenabis – a Maltese joint venture and partner of Zenpharm, have received a licence for the production of medical cannabis in their facility in Hal Far, Malta.”
The CEO said that the issuing of the second licence for the production of cannabis for medical use shows that “Malta is becoming a centre of excellence in such an important emerging sector.”
“Those companies strive hard to achieve the Medicine’s Authority pharmaceutical standards. Now that they do, patients can rest assured that the Made in Malta product is top quality. A gold standard for the industry. This is indeed a proud moment.”
Through its licence, ZenPharm plans to ship around 500kg of cannabis out of Malta annually to EU countries, with the largest market being Germany.
Featured Image:
Kurt Farrugia / LinkedIn
Is it true that working mothers are less committed to work? Jenna Vassallo thinks not
She is quite vociferous in advocating the improvement of parental leave policies.
Malta Stock Exchange holds annual awards dinner
APS Bank CEO and Chairman of the Malta Bankers’ Association, Marcel Cassar, was a guest of honour at the dinner.
Will stores have a bigger storm to weather this Black Friday?
'Inflation, the war and all the other uncertainties that Malta is facing, might actually be bigger threats than the weather ...
Why should companies speak openly about the salaries they offer?
Recruiter Francesca Ellul stresses the importance of salary transparency when advertising vacancies.
